I agree that this site is using cookies. You can find further informations here.
X
Lorenzato, Christelle
35  results:
Search for persons X
?
1

A Multi-Arm Two-Stage (MATS) design for proof-of-concept an..:

Jiang, Zhenghao ; Mi, Gu ; Lin, Ji..
Contemporary Clinical Trials.  132 (2023)  - p. 107278 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Enhancement of Basket Trial Designs with Incorporation of a..:

Mi, Gu ; Yang, Yue ; Jin, Zhumengmeng..
Statistics in Biopharmaceutical Research.  , 2023
Link: https://doi.org/10.1080/..
 
?
3

Current perspectives for external control arms in oncology ..:

Wang, Xiaomeng ; Dormont, Flavio ; Lorenzato, Christelle...
Journal of Cancer Policy.  35 (2023)  - p. 100403 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Bayesian modeling of a bivariate toxicity outcome for early..:

Gerard, Emma ; Zohar, Sarah ; Lorenzato, Christelle..
Statistics in Medicine.  40 (2021)  23 - p. 5096-5114 , 2021
Link: https://doi.org/10.1002/..
 
?
5

Bayesian dose regimen assessment in early phase oncology in..:

Gerard, Emma ; Zohar, Sarah ; Thai, Hoai‐Thu...
Biometrics.  78 (2021)  1 - p. 300-312 , 2021
Link: https://doi.org/10.1111/..
 
?
6

Safety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 ..:

Jones, Peter H. ; Bays, Harold E. ; Chaudhari, Umesh...
The American Journal of Cardiology.  118 (2016)  12 - p. 1805-1811 , 2016
Link: https://doi.org/10.1016/..
 
?
7

Efficacy and Safety of Alirocumab in Patients with Heterozy..:

Ginsberg, Henry N. ; Rader, Daniel J. ; Raal, Frederick J....
Cardiovascular Drugs and Therapy.  30 (2016)  5 - p. 473-483 , 2016
Link: https://doi.org/10.1007/..
 
?
8

Efficacy and safety of alirocumab in high cardiovascular ri..:

Cannon, Christopher P. ; Cariou, Bertrand ; Blom, Dirk...
European Heart Journal.  36 (2015)  19 - p. 1186-1194 , 2015
Link: https://doi.org/10.1093/..
 
?
9

Adaptive and repeated cumulative meta‐analyses of safety da..:

Quan, Hui ; Ma, Yingqiu ; Zheng, Yan...
Pharmaceutical Statistics.  14 (2015)  3 - p. 161-171 , 2015
Link: https://doi.org/10.1002/..
 
?
10

ODYSSEY FH I and FH II: 78 week results with alirocumab tre..:

Kastelein, John J.P. ; Ginsberg, Henry N. ; Langslet, Gisle...
European Heart Journal.  , 2015
Link: https://doi.org/10.1093/..
 
?
11

Efficacy and safety of the proprotein convertase subtilisin..:

Kereiakes, Dean J. ; Robinson, Jennifer G. ; Cannon, Christopher P....
American Heart Journal.  169 (2015)  6 - p. 906-915.e13 , 2015
Link: https://doi.org/10.1016/..
 
?
12

Efficacy and Safety of Alirocumab in Patients with Heterozy..:

Kastelein, John J. P. ; Robinson, Jennifer G. ; Farnier, Michel...
Cardiovascular Drugs and Therapy.  28 (2014)  3 - p. 281-289 , 2014
Link: https://doi.org/10.1007/..
 
?
13

Efficacy and safety of alirocumab, a fully human PCSK9 mono..:

Colhoun, Helen M ; Robinson, Jennifer G ; Farnier, Michel...
BMC Cardiovascular Disorders.  14 (2014)  1 - p. , 2014
Link: https://doi.org/10.1186/..
 
?
14

A Multi-Arm Two-Stage (MATS) Design for Proof-of-Concept an..:

Jiang, Zhenghao ; Mi, Gu ; Lin, Ji..
http://arxiv.org/abs/2304.06164.  , 2023
Link: http://arxiv.org/abs/230..
 
?
15

Bayesian dose‐regimen assessment in early phase oncology in..:

Gerard, Emma ; Zohar, Sarah ; Thai, Hoai‐thu...
info:eu-repo/semantics/altIdentifier/arxiv/2011.11480.  , 2022
Link: https://hal.science/hal-..
 
1-15